Nova Labs manufactures first aseptically spray dried biologic
Nova Laboratories has welcomed the US FDA’s approval of Raplixa from ProFibrix, a Netherlands-based wholly owned subsidiary of The Medicines Company. Raplixa is manufactured at Nova Laboratories sterile manufacturing facilities in the UK and consists of spray dried thrombin and fibrinogen, which are blended and filled aseptically.
See more at:
http://www.manufacturingchemist.com/news/article_page/Nova_Laboratories_manufactures_first_aseptically_spray_dried_biologic/108345